ADC Therapeutics (NYSE:ADCT) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS
ADC Therapeutics (NYSE:ADCT - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.19) by $0.06. The firm had revenue of $20.85 million during the quarter, compared to analysts...